Centers for Diabetes Translation Research (CDTR)

May 2024 Council

Lead Division/Office


Point(s) of Contact

Shavon Artis Dickerson, Dr.P.H., M.P.H.; Rafael Gorospe, M.D., Ph.D.; Pamela Thornton, Ph.D.

Executive Summary

The Centers for Diabetes Translation Research (CDTR) program was established in 2011 to improve translation of research findings related to diabetes prevention, treatment, and health equity by supporting research across the translational research spectrum (i.e., bedside to clinical practice and community settings, dissemination and implementation research). CDTRs provide local, regional, and national research resources to advance the field of diabetes translation, address diabetes-related health disparities, and develop the scientific workforce. The goal of CDTRs ( is to improve prevention/treatment of diabetes by promoting research that supports rapid dissemination, implementation, and sustained use of effective interventions/approaches, particularly in high-risk populations.CDTRs have documented evidence of progress from their current project period, which is the second renewal with seven funded grantees. To date, their scientific research base consists of over 790 members, over 4,000 consultation services across 24 local, regional, and national research service cores, and awarded 94 P&F projects. The objective of this renewal is to ensure uninterrupted support to the CDTR program after the current project period ending 6/30/2026. This will be a competitive renewal open to existing and new Center applications.